These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 29534654)

  • 41. Trends in CD4 cell count response to first-line antiretroviral treatment in HIV-positive patients from Asia, 2003-2013: TREAT Asia HIV Observational Database Low Intensity Transfer.
    De La Mata NL; Ly PS; Ng OT; Nguyen KV; Merati TP; Pham TT; Lee MP; Choi JY; Sohn AH; Law MG; Kumarasamy N
    Int J STD AIDS; 2017 Nov; 28(13):1282-1291. PubMed ID: 28632481
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Factors associated with death and loss to follow-up in children on antiretroviral care in Mingalardon Specialist Hospital, Myanmar, 2006-2016.
    Kaung Nyunt KK; Han WW; Satyanarayana S; Isaakidis P; Hone S; Khaing AA; Nguyen Binh H; Oo HN
    PLoS One; 2018; 13(4):e0195435. PubMed ID: 29621302
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Predictors of Treatment Failure among Adult Antiretroviral Treatment (ART) Clients in Bale Zone Hospitals, South Eastern Ethiopia.
    Haile D; Takele A; Gashaw K; Demelash H; Nigatu D
    PLoS One; 2016; 11(10):e0164299. PubMed ID: 27716827
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Improved survival in HIV treatment programmes in Asia.
    De La Mata NL; Kumarasamy N; Khol V; Ng OT; Van Nguyen K; Merati TP; Pham TT; Lee MP; Durier N; Law M
    Antivir Ther; 2016; 21(6):517-527. PubMed ID: 26961354
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CD4 count at antiretroviral therapy initiation and the risk of loss to follow-up: results from a multicentre cohort study.
    Grimsrud A; Cornell M; Schomaker M; Fox MP; Orrell C; Prozesky H; Stinson K; Tanser F; Egger M; Myer L;
    J Epidemiol Community Health; 2016 Jun; 70(6):549-55. PubMed ID: 26700300
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Early mortality among children and adults in antiretroviral therapy programs in Southwest Ethiopia, 2003-15.
    Gesesew HA; Ward P; Woldemichael K; Mwanri L
    PLoS One; 2018; 13(6):e0198815. PubMed ID: 29912974
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2012 Jun; 30(6):e1-89. PubMed ID: 22633764
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Attrition among HIV positive children enrolled under integrated HIV care programme in Myanmar: 12 years cohort analysis.
    Minn AC; Kyaw NTT; Aung TK; Mon OM; Htun T; Oo MM; Moe J; Mon AA; Satyanarayana S; Oo HN
    Glob Health Action; 2018; 11(1):1510593. PubMed ID: 30191749
    [TBL] [Abstract][Full Text] [Related]  

  • 49. AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study.
    Ledergerber B; Egger M; Erard V; Weber R; Hirschel B; Furrer H; Battegay M; Vernazza P; Bernasconi E; Opravil M; Kaufmann D; Sudre P; Francioli P; Telenti A
    JAMA; 1999 Dec; 282(23):2220-6. PubMed ID: 10605973
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characteristics and outcomes of adult Ethiopian patients enrolled in HIV care and treatment: a multi-clinic observational study.
    Melaku Z; Lamb MR; Wang C; Lulseged S; Gadisa T; Ahmed S; Habtamu Z; Alemu H; Assefa T; Abrams EJ
    BMC Public Health; 2015 May; 15():462. PubMed ID: 25934178
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevalence, predictors, and management of advanced HIV disease among individuals initiating ART in Senegal, West Africa.
    Benzekri NA; Sambou JF; Ndong S; Tamba IT; Faye D; Diallo MB; Diatta JP; Faye K; Sall I; Sall F; Manga NM; Malomar JJ; Ndour CT; Hawes SE; Seydi M; Gottlieb GS
    BMC Infect Dis; 2019 Mar; 19(1):261. PubMed ID: 30876400
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tuberculosis incidence rate and risk factors among HIV-infected adults with access to antiretroviral therapy.
    Liu E; Makubi A; Drain P; Spiegelman D; Sando D; Li N; Chalamilla G; Sudfeld CR; Hertzmark E; Fawzi WW
    AIDS; 2015 Jul; 29(11):1391-9. PubMed ID: 26091295
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Retention in care among HIV-positive patients initiating second-line antiretroviral therapy: a retrospective study from an Ethiopian public hospital clinic.
    Wilhelmson S; Reepalu A; Balcha TT; Jarso G; Björkman P
    Glob Health Action; 2016; 9():29943. PubMed ID: 26765104
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Trends Over Time for Adolescents Enrolling in HIV Care in Kenya, Tanzania, and Uganda From 2001-2014.
    Apondi E; Humphrey JM; Sang E; Mwangi A; Keter A; Musick BS; Nalugoda FK; Ssali J; Bukusi E; Yiannoutsos CT; Wools-Kaloustian K; Ayaya S
    J Acquir Immune Defic Syndr; 2018 Oct; 79(2):164-172. PubMed ID: 29985263
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Implementation and Operational Research: High Loss to Follow-up Among Children on Pre-ART Care Under National AIDS Program in Madurai, South India.
    Ganga Devi NP; Ajay KM; Palanivel C; Sahu S; Selvaraj M; Valan AS; Rewari BB; Soumya S
    J Acquir Immune Defic Syndr; 2015 Jul; 69(3):e109-14. PubMed ID: 26181709
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Brief Report: Does Most Mortality in Patients on ART Occur in Care or After Lost to Follow-Up? Evidence From the Themba Lethu Clinic, South Africa.
    Budgell EP; Maskew M; Long L; Sanne I; Fox MP
    J Acquir Immune Defic Syndr; 2015 Nov; 70(3):323-8. PubMed ID: 26181816
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mortality associated with delays between clinic entry and ART initiation in resource-limited settings: results of a transition-state model.
    Hoffmann CJ; Lewis JJ; Dowdy DW; Fielding KL; Grant AD; Martinson NA; Churchyard GJ; Chaisson RE
    J Acquir Immune Defic Syndr; 2013 May; 63(1):105-11. PubMed ID: 23392457
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Switch from 200 to 350 CD4 baseline count: what it means to HIV care and treatment programs in Kenya.
    Mwangi J; Nganga Z; Lihana R; Lagat N; Kinyua J; Muriuki J; Maiyo A; Kinyua F; Okoth F; Mpoke S
    Pan Afr Med J; 2012; 12():80. PubMed ID: 23077701
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The presence of CD4 counts for the management of HIV patients in East Africa: a multicentred study.
    Harding R; Simms V; Penfold S; Downing J; Powell RA; Mwangi-Powell F; Namisango E; Moreland S; Gikaara N; Atieno M; Kataike J; Nsubuga C; Munene G; Banga G; Higginson IJ
    AIDS Care; 2014; 26(5):613-8. PubMed ID: 24099416
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Lost Art of Documentation.
    Sanderson AL
    Pediatr Crit Care Med; 2022 Feb; 23(2):138-140. PubMed ID: 35119433
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.